Monitoring in IBD - When, Why, and How

At the conclusion of this activity, the participants should be better able to:

1. Discuss why it is important to treat-to-target in Inflammatory Bowel disease (IBD).
2. Define current strategies and timeline for treat-to-target in IBD.
3. Identify potential barriers to achieve these targets.

6:00 p.m.  –  Registration / Reception / Exhibits

6:45 p.m.  –  Dinner

7:15 p.m.  –  Educational Program and Discussions

8:15 p.m.  –  Adjourn

In support of improving patient care, University of Nebraska Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians

The University of Nebraska Medical Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses

The University of Nebraska Medical Center designates this activity for 1.0 ANCC contact hour. Nurses should only claim credit for the actual time spent participating in the activity.

If you registered for this activity but are now unable to attend, please email registrationCCE@unmc.edu so we can cancel your registration.

If you have any accessibility needs or medically indicated dietary requirements, please email Tori Greenlee by Feb. 6, 2026, so appropriate accommodations can be arranged.

Read the UNMC CCE Disclosure Declaration Policy

Disclosures

The accredited provider has mitigated and is disclosing identified relevant financial relationships for the following faculty, planners, and others in control of content prior to assuming their roles.

FACULTY

The following has disclosed a relevant financial relationship:

• Kayci Huff-Hardy, MD, PhD
  Consultant: Genentech, Inc.; Lilly USA, LLC

PLANNING COMMITTEE

The following has disclosed a relevant financial relationship:

• Faruq Pradhan, MBBCh, FRCPC
  Advisory Board: Ipsen Pharma; Madrigal Pharmaceuticals, Inc.

The following have nothing to disclose:

• Valeta Creason-Wahl, CAPM, MMP
• Tori Greenlee
• Heidi Keeler, PhD, MSN/MBA, RN
• Carrie R. Nixon, PharmD, RPh
• Renee Paulin, DNP, MSN, RN, CWOCN
• Fedja Rochling, MBBCh, MBA
• Shannan Wilson, RRT

To ensure that our conference materials are inclusive and accessible to all attendees, we have updated how we share session content. In alignment with digital accessibility standards, we no longer host traditional handout uploads on our site. Speakers have been encouraged to include their contact information within their presentations so that attendees may reach out to them directly for materials or follow-up questions in a format that works best for them.